Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32861573.
- Also identified by DOI 10.1016/j.eururo.2020.08.027 and PMC identifier 7448869.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Our understanding of the mechanism of bacillus Calmette-Guérin (BCG) in controlling urothelial carcinoma is still evolving. Studies have revealed a complex and multifaceted immune response. BCG-elicited adaptive antitumor immunity directed towards tumor antigens could have major implications for trial design.
Medical subject headings
- Carcinoma, Transitional Cell
- Urinary Bladder Neoplasms